Literature DB >> 7982640

Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis.

S Fargion1, A L Fracanzani, A Piperno, M Braga, R D'Alba, G Ronchi, G Fiorelli.   

Abstract

To identify factors that might be useful as prognostic indexes for the risk of hepatocellular carcinoma in Italian patients with genetic hemochromatosis, 152 homozygotes were studied prospectively for 1 to 229 mo. Factors that were considered in estimating the risk of developing hepatocellular carcinoma were age, sex, cirrhosis (Child class), HBsAg, antibodies to HBsAg, antibodies to HBcAg, hepatitis C antibodies, alcohol abuse and the amount of iron removed during therapeutic phlebotomy to produce iron depletion. At diagnosis, cirrhosis was present in 97 patients and absent in 55. During follow-up, hepatocellular carcinoma developed in 28 of the 97 patients with cirrhosis but in none of those without. Among patients with cirrhosis, the cumulative probability of being free of hepatocellular carcinoma at 10 yr was 70%. For patients with and without HBsAg the probabilities of being free of liver cancer at 10 yr were, respectively, 54% and 75%; for those with and without history of alcoholism, 58% and 78%; and for those younger and older than 55 yr, 90% and 54%. In patients with cirrhosis, multivariate analysis using proportional-hazards (Cox) regression found that the only factors contributing significantly to the estimation of a prognostic index were age, presence of HBsAg and alcohol abuse. Age over 55 yr increased the relative risk of hepatocellular carcinoma 13.3-fold (p < 0.001), the presence of HBsAg increased it 4.9-fold (p < 0.02) and alcohol abuse increased it 2.3-fold (p < 0.04).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982640     DOI: 10.1002/hep.1840200608

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

1.  The diagnosis and management of hereditary haemochromatosis.

Authors:  Paul Clark; Laurence J Britton; Lawrie W Powell
Journal:  Clin Biochem Rev       Date:  2010-02

2.  Hepatic loss in a young patient: a very 'cold case'.

Authors:  Vincenzo De Francesco; Enzo Ierardi; Giuseppe Stoppino; Fabrizio Corsi; Maria Rosaria D'Agnessa; Michele Castriota; Cesare Hassan; Francesco Cianci; Angelo Zullo
Journal:  Intern Emerg Med       Date:  2011-03-23       Impact factor: 3.397

3.  Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats.

Authors:  J Kato; M Kobune; Y Kohgo; N Sugawara; H Hisai; T Nakamura; S Sakamaki; N Sawada; Y Niitsu
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

4.  Transferrin saturation, dietary iron intake, and risk of cancer.

Authors:  Arch G Mainous; James M Gill; Charles J Everett
Journal:  Ann Fam Med       Date:  2005 Mar-Apr       Impact factor: 5.166

Review 5.  Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.

Authors:  Francesca Lodato; Giuseppe Mazzella; Davide Festi; Francesco Azzaroli; Antonio Colecchia; Enrico Roda
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

6.  Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.

Authors:  Luca Valenti; Paolo Maggioni; Alberto Piperno; Raffaela Rametta; Sara Pelucchi; Raffaella Mariani; Paola Dongiovanni; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

7.  3,5,5-trimethyl-hexanoyl-ferrocene diet protects mice from moderate transient acetaminophen-induced hepatotoxicity.

Authors:  Mi Sun Moon; Boo-Hyon Kang; Jacek Krzeminski; Shantu Amin; Cesar Aliaga; Junjia Zhu; Emily I McDevitt; Susan Kocher; John P Richie; Harriet C Isom
Journal:  Toxicol Sci       Date:  2011-09-09       Impact factor: 4.849

8.  Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis.

Authors:  Paola Dongiovanni; Anna Ludovica Fracanzani; Gaetano Cairo; Chiara Paola Megazzini; Stefano Gatti; Raffaela Rametta; Silvia Fargion; Luca Valenti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

Review 9.  HFE gene in primary and secondary hepatic iron overload.

Authors:  Giada Sebastiani; Ann-P Walker
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 10.  The clinical management of hereditary haemochromatosis.

Authors:  Marinos Pericleous; Claire Kelly
Journal:  Frontline Gastroenterol       Date:  2017-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.